| Primary |
| Product Used For Unknown Indication |
83.3% |
| Intentional Overdose |
16.7% |
|
| Coma |
33.3% |
| Overdose |
33.3% |
| Pancreatic Enzymes Increased |
33.3% |
|
| Secondary |
| Product Used For Unknown Indication |
24.6% |
| Hiv Infection |
15.0% |
| Drug Use For Unknown Indication |
9.6% |
| Crohn's Disease |
8.6% |
| Pain |
5.9% |
| Prophylaxis |
4.3% |
| Influenza |
3.7% |
| Hypertension |
3.2% |
| Liver Transplant |
3.2% |
| Overdose |
2.7% |
| Diarrhoea |
2.1% |
| Erysipelas |
2.1% |
| Flatulence |
2.1% |
| Osteitis |
2.1% |
| Tuberculosis |
2.1% |
| Vomiting |
2.1% |
| Anticoagulant Therapy |
1.6% |
| Back Pain |
1.6% |
| Chronic Hepatitis C |
1.6% |
| Dizziness |
1.6% |
|
| Pancreatitis Acute |
13.5% |
| Renal Failure Acute |
10.8% |
| Death |
8.1% |
| Pulmonary Fibrosis |
8.1% |
| Abdominal Pain Upper |
5.4% |
| Fall |
5.4% |
| Hepatic Artery Thrombosis |
5.4% |
| Hypoglycaemia |
5.4% |
| Overdose |
5.4% |
| Vomiting |
5.4% |
| Agranulocytosis |
2.7% |
| Altered State Of Consciousness |
2.7% |
| Arthralgia |
2.7% |
| Blood Glucose Increased |
2.7% |
| Completed Suicide |
2.7% |
| Cytolytic Hepatitis |
2.7% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.7% |
| Hyperreflexia |
2.7% |
| Inflammation |
2.7% |
| Intentional Overdose |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.1% |
| Product Used For Unknown Indication |
19.9% |
| Hypertension |
6.1% |
| Diarrhoea |
4.9% |
| Nervous System Disorder |
4.9% |
| Rheumatoid Arthritis |
4.7% |
| Breast Cancer |
4.3% |
| Pain |
3.9% |
| Crohn's Disease |
3.7% |
| Constipation |
3.6% |
| Gastrointestinal Disorder |
2.9% |
| Cardiovascular Disorder |
2.8% |
| Abdominal Pain |
2.6% |
| Multiple Sclerosis |
2.6% |
| Mucopolysaccharidosis Ii |
2.5% |
| Prostate Cancer |
2.3% |
| Irritable Bowel Syndrome |
2.2% |
| Osteoporosis |
2.1% |
| Nausea |
2.0% |
| Prophylaxis |
2.0% |
|
| Thrombocytopenia |
11.4% |
| Urinary Tract Infection |
9.5% |
| Diverticulitis Intestinal Haemorrhagic |
7.6% |
| Vomiting |
6.7% |
| Myelodysplastic Syndrome |
5.7% |
| Pneumonia |
5.7% |
| Renal Failure Acute |
4.8% |
| Subdural Haemorrhage |
4.8% |
| Thyroid Cancer |
4.8% |
| Anal Stenosis |
3.8% |
| Hyponatraemia |
3.8% |
| Nausea |
3.8% |
| Nephrolithiasis |
3.8% |
| Pain |
3.8% |
| Sepsis |
3.8% |
| Transient Ischaemic Attack |
3.8% |
| Varices Oesophageal |
3.8% |
| Acute Generalised Exanthematous Pustulosis |
2.9% |
| Agranulocytosis |
2.9% |
| Cholestasis |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
77.8% |
| Contraception |
11.1% |
| Pharyngitis |
11.1% |
|
| Maternal Exposure During Pregnancy |
100.0% |
|
